ArticleCancers2023

Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes.

Nobuaki Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.